Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Randomized Controlled Trial of Dapagliflozin on Left Ventricular Hypertrophy in People With Type Two Diabetes: The DAPA-LVH TrialEur Heart J 2020 Jun 24;[EPub Ahead of Print], AJM Brown, S Gandy, R McCrimmon, JG Houston, AD Struthers, CC Lang
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.